| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |